Black Titan Corporation was formed for the purpose of effecting a merger between Titan Pharmaceuticals Inc. and TalenTec Sdn Bhd. The company offers human capital management solutions and is also focused on strategic expansion into the digital asset and blockchain sectors.
DeFi-as-a-Service, Lending-as-a-Service and the Bank-Issued Rails
Black Titan Corp (NASDAQ: BTTC) published a weekly research note surveying digital-asset developments, framing the sector's shift from product experimentation to distribution-embedded infrastructure across DeFi, lending, and bank-issued rails.
Highlights include Compound's day-one oversubscribed USDC Institutional Market backed by a USD 52 million program, Coinbase extending Morpho-powered USDC lending to Brazil, U.S. Bank's live USBDC stablecoin pilot on Stellar, and Qivalis confirming public-Ethereum issuance for its 37-bank euro stablecoin.
The note cites USD 39.2 billion of on-chain real-world asset value with holder growth above 100% in 30 days, while flagging secondary liquidity and unresolved governance structures as the sector's binding constraints.
No BTTC-specific financial results, transactions, or guidance were disclosed; the company describes its DAT+ strategy as using its balance sheet to support, govern, and provide liquidity to decentralized protocols, making the constructive sector view strategically aligned but not a corporate event.